Belize Cannabis Tours, Crique Troso (Mafredi), 18 Miles San Antonio Road (2026)

05/03/2026

A state audit released on February 18 found that hundreds of Missouri cannabis businesses may have gained medical ma*****na licenses in 2019 through an application and evaluation process described as flawed, inconsistent, and lacking transparency.

State Auditor Scott Fitzpatrick reported that the Missouri Division of Cannabis Regulation did not properly establish its blind scoring system when awarding 348 medical cannabis licenses more than six years ago. Out of 2,257 applicants, the division granted 192 dispensary licenses, 86 manufacturing licenses, 60 cultivation licenses, and 10 testing laboratory licenses. Most of these businesses now operate in Missouri’s $1.5 billion cannabis market, which expanded to include recreational sales in 2023, giving the original license holders an early advantage.

The 77 page audit reviewed 67 license applications, about 3 percent of the total. According to Fitzpatrick, the review showed that applicants were allowed to create their own identifying codes during the supposedly anonymous scoring process. About 18 percent used identifiers connected to their company names, making it possible for reviewers to recognize who submitted the application. These applicants were not penalized for breaking the redaction rules.

Based on the sample, roughly 405 of the 2,257 applicants may have used identifiable codes. The audit also found that about 83 percent of applicants who used company based identifiers won licenses, compared with only 15 percent of applicants overall.

However, the sample used in the audit may not accurately reflect the full pool of applicants. The selection of the 67 applications included a higher proportion of successful applicants than existed in the original pool, meaning the results could be skewed.

Despite this, Fitzpatrick maintained that the findings highlight serious problems. He said the process that was supposed to be anonymous could be bypassed by applicants revealing clues about their identity, and those applicants were far more likely to receive licenses. According to him, such issues damage trust in the fairness of the licensing system.

The audit also identified several scoring inconsistencies and procedural weaknesses that contributed to about $12.5 million in legal costs between 2020 and 2023. Appeals from unsuccessful applicants led to 68 additional licenses being issued.

Another concern raised in the audit involved Wise Health Solutions, the company hired to evaluate applications. The report stated that graders were discouraged from writing notes explaining their scoring decisions. A manual reportedly advised evaluators to follow the saying: “Say it and forget it, write it and regret it.”

In response, the Missouri Department of Health and Human Services, which oversees the Division of Cannabis Regulation, rejected many of the audit’s conclusions. In a 23 page reply signed by Director Sarah Willson and DCR Director Amy Moore, the department argued that the licensing process had already been reviewed by the state’s Administrative Hearing Commission, which repeatedly found the scoring system to be consistent and fair.

They also criticized the audit’s methodology, especially the sample of 67 applications. Of those, 42 were randomly selected while 25 were chosen intentionally by the auditor’s office. The department said this created a biased and unrepresentative sample.

Within the audit sample, 48 percent of applicants were approved and 52 percent were denied. In reality, only about 15 percent of the total 2,257 applicants received licenses, while 85 percent were rejected. Because of this imbalance, the department argued that the audit likely overstated the number of applicants who used identifiable codes.

Although the audit ultimately rated the state’s cannabis program as “fair,” Fitzpatrick said the issues uncovered still raise concerns about the integrity of the licensing process. He also claimed that the health department was uncooperative during the audit and used hostile language in its response.

Fitzpatrick said audits are meant to help improve government operations and expressed hope that the department would treat the report as a guide for improving its procedures.

The report also recommended stronger oversight of cannabis inventory to reduce the risk of products entering the illegal market. It criticized the state’s track and trace system, Metrc, saying it could not reliably detect purchases that exceed legal limits in real time. This could allow customers to buy more cannabis than permitted under state law.

Health department officials rejected that criticism as well, arguing that the auditor’s office misunderstood how cannabis regulation works. They said the state relies primarily on seed to sale data analysis rather than physical inspections to detect diversion, which they described as the industry standard in regulated cannabis markets.

While the department said it welcomes constructive feedback, it concluded that the audit’s findings were largely speculative and based on misunderstandings of the licensing system and the state’s regulatory oversight.

02/03/2026

As cannabinoid h**p growers continue battling uncertainty about their future, industrial h**p producers may find more stability in 2026 through a proposed five-year farm bill reauthorization.

On Feb. 13, Glenn "GT" Thompson, chair of the House Agriculture Committee, introduced the Farm, Food, and National Security Act of 2026. The 802-page proposal, House Resolution 7567, is scheduled for markup beginning Feb. 23.

According to a summary from Thompson’s office, the bill aims to ease regulatory pressure on industrial h**p farmers. It would permit the U.S. Department of Agriculture (USDA), along with states and tribal authorities, to scale back or eliminate certain testing requirements and background checks.

The proposal directs the USDA to work with the Drug Enforcement Administration (DEA) to create a system for accrediting h**p-testing laboratories. This change would eliminate the requirement that labs be DEA-registered—an enforcement step the USDA has repeatedly postponed due to limited DEA-approved lab capacity.

The draft also allows industrial h**p producers to reduce sampling and testing obligations by using visual inspections, performance-based sampling methods, certified seed, or similar procedures when developing compliance plans.

Under the 2026 language, farmers could self-identify their operations as producing “only industrial h**p,” such as fiber or grain, or as h**p grown for other purposes, including cannabinoids. Those designating themselves as “only industrial h**p” producers would no longer face a 10-year ban from participation if previously convicted of a controlled-substance-related felony. However, growers who falsely claim industrial status and cultivate outside that definition would face a five-year program ineligibility penalty.

The Republican-backed bill follows President Donald Trump signing a government funding measure in November 2025 that included a provision banning intoxicating consumable h**p products starting in November 2026. The ban covers products with synthetic cannabinoids like delta-8 THC, unnatural compounds such as HHC, and items exceeding 0.3% total THC (including THCA) or 0.4 milligrams of total THC per container.

After the ban was included in the funding package, lawmakers introduced companion legislation to delay its implementation until November 2028, arguing that cannabinoid h**p farmers need additional time to adjust.

Kentucky farmer Brian Furnish, an eighth-generation grower, said he turned to h**p in 2014 under his state’s pilot program to offset declining to***co revenues. Now, he says, another regulatory shift threatens his livelihood and land value. Without a two-year extension, he argues, farmers like him will be unable to sell h**p harvested and planted legally in 2025.

The 2026 Farm Bill proposal does not provide relief for cannabinoid producers. Instead, it aligns with the forthcoming product ban by eliminating the 0.3% delta-9 THC threshold established in the 2018 farm bill—often described as the “loophole” that enabled widespread sales of intoxicating h**p products. The new draft replaces it with a total THC standard, including THCA, capped at 0.3% in the plant.

Rep. James Baird, a member of the House Agriculture Committee, is leading the H**p Planting Predictability Act to delay the federal ban by two years. The bill is co-sponsored by the committee’s ranking member, Rep. Angie Craig. Although they could attempt to attach their measure to the farm bill, Thompson has indicated that regulation of finished consumable h**p products falls outside the Agriculture Committee’s jurisdiction.

The federal farm bill, reauthorized 18 times since 1933, governs a broad range of agricultural and food programs—from nutrition assistance such as SNAP to crop insurance, conservation, fertilizer, and energy policies. Thompson has described the new proposal as overdue and necessary to provide clarity for farmers, ranchers, and rural communities nationwide.

While cannabinoid h**p producers may see the 2026 draft as another setback to business models developed under the 2018 framework, industrial h**p growers may view it as reinforcing their legitimacy.

Geoff Whaling, chair of the National H**p Association (NHA), said the h**p provisions reflect a major policy shift. He described the draft as tightening and clarifying h**p’s federal definition while emphasizing its status as an agricultural commodity rather than a pathway to intoxicating THC markets. According to Whaling, the goal is to protect industrial h**p while closing the loophole that allowed intoxicating cannabinoid products to expand outside regulated ma*****na systems.

27/02/2026

After multiple unsuccessful efforts to fully legalize recreational cannabis, Hawaii’s most realistic opportunity in 2026 may be a narrower proposal focused on limited consumer access rather than a comprehensive commercial system.

On Feb. 18, the Hawaii Senate Health and Human Services Committee unanimously advanced Senate Bill 3275, which would permit adults 21 and older to use low-dose, low-potency cannabis starting Jan. 1, 2027. The bill defines qualifying products as those containing no more than 5 milligrams of THC per serving, including per 12-ounce beverage. However, it does not create a licensed and regulated marketplace for cultivation, manufacturing, or retail sales.

Instead, the proposal would allow individuals 21 and older to “dispense or otherwise sell” these low-dose products to other adults 21 and up, who could then legally smoke or consume them. The language also appears broad enough to potentially allow unlicensed businesses to participate.

Introduced by Democratic Sen. Joy San Buenaventura, the measure requires that any low-dose cannabis distributed by a business be packaged in sealed, child-resistant, resealable containers with original labels and kept out of reach of anyone under 21.

The bill initially included provisions for personal cultivation, requiring homegrown cannabis to be stored securely away from minors. However, the committee amended the legislation to remove specific guidelines about how many plants adults could grow and how much cannabis they could process or store. Instead, the Office of Medical Cannabis Control and Regulation would be tasked with developing rules governing personal cultivation, including safeguards to prevent diversion into illegal markets.

Lawmakers also stripped out protections for adult-use consumers in several areas. The amended version removes safeguards related to medical care, including potential organ or tissue transplant eligibility, as well as protections concerning child custody and visitation rights. Workplace protections for employees who test positive for cannabis were also eliminated.

This scaled-back proposal follows broader legalization bills passed by the Hawaii Senate in 2023 and 2024 that were ultimately blocked by the Hawaii House. In 2025, a House-originated legalization bill stalled after Democratic Rep. Chris Todd moved to recommit it, citing insufficient support.

A similar pattern has played out again this year, with the House declining to act on two legalization measures, including one that would have placed the issue before voters in November 2026. Although Hawaii does not allow citizen-initiated ballot measures, the Legislature can refer constitutional amendments to voters. However, House Speaker Nadine Nakamura indicated there were not enough votes to advance the proposal.

Public opinion appears to favor legalization. A late 2023 Hawai’i Perspectives poll by Pacific Resource Partnership found that 58% of adults in the state support legalizing recreational cannabis.

Hawaii was once considered a leader in cannabis reform, becoming the first state to legalize medical cannabis through legislation in 2000. Today, however, it remains the oldest medical-only cannabis state and the only state with a Democratic-controlled Legislature and governor that has yet to legalize adult use.

With comprehensive legalization still facing resistance in the House, the Senate’s narrower low-dose proposal may represent the state’s best chance to move reform forward.

25/02/2026

Adults age 21 and older in Virginia could gain access to licensed cannabis dispensaries later this year after lawmakers advanced legislation to legalize retail sales.

On Feb. 17, the Virginia House and Senate approved similar measures—House Bill 642 and Senate Bill 542—moving the state closer to establishing a regulated adult-use market. With Democrats now holding the governorship under Abigail Spanberger, along with both legislative chambers, momentum has returned to a reform effort that has taken years to materialize.

The proposals focus heavily on strict safety, packaging, and retail regulations. Lawmakers emphasized childproof packaging, ID checks at entry and purchase, and restrictions on flashy storefront advertising. Both bills would empower the Virginia Cannabis Control Authority to oversee licensing and regulation of cultivation, processing, testing, and retail sales. The Senate version would merge cannabis oversight into the state’s alcohol regulator, forming a combined authority.

Under both plans, adults could purchase up to 2.5 ounces of cannabis flower (or equivalent products). Edibles would be limited to 10 milligrams of THC per serving and 100 milligrams per package.

The timeline for launching retail sales differs slightly. The House version would allow existing medical cannabis operators to begin adult-use sales by November 2026 with a $5 million transition fee, while the Senate version sets a January 2027 start date with a $15 million fee. Regulators could begin accepting applications for additional licenses in mid-2026, possibly using a lottery system.

Unlike some other states, Virginia’s proposal would not allow local governments to opt out of hosting dispensaries, a move lawmakers say will help curb unregulated sales. The legislation also includes enforcement measures aimed at cracking down on illicit markets.

Before 2028, regulators could license up to 350 dispensaries and five large-scale cultivation facilities, with additional smaller cultivation tiers available. After that, authorities would determine license numbers based on supply, competition, and market stability.

Both bills would create a Cannabis Equity Reinvestment Fund to support communities disproportionately impacted by past drug enforcement. Revenue allocation differs slightly between the House and Senate versions, but funding would support equity programs, behavioral health services, early childhood education, and public health initiatives.

Tax structures also vary. The House bill proposes a 6% cannabis excise tax plus standard sales tax and a potential local tax of up to 3.5%. The Senate version includes a higher excise tax but lowers the general sales tax portion and caps the local tax at 3%.

The effort builds on a 2021 legalization law signed by former Gov. Ralph Northam, which legalized possession and limited home cultivation but did not establish a retail market. Subsequent attempts were vetoed by former Gov. Glenn Youngkin.

Now, with Democratic control restored, Virginia could become the 24th state to launch adult-use cannabis sales if lawmakers reconcile the remaining differences between the two bills.

19/02/2026

llinois Cannabis Revenues Down 13% Despite More Items Sold

Cannabis revenue in Illinois fell 13% last year to $1.5 billion, according to figures reported by the Chicago Tribune. Even with the drop in revenue, total product sales climbed to 58 million items in 2024, signaling a significant decline in prices. When adult-use sales first began in 2020, an ounce of flower averaged over $400; by the close of last year, that price had fallen to roughly $167.
A comparable pattern emerged in Michigan in 2025, where retailers moved 260,000 more pounds of cannabis than the year before. However, total sales reached about $3.17 billion—$113 million lower than 2024’s overall revenue.

Illinois’ 2025 Annual Cannabis Report notes that the state’s cannabis sector employs approximately 9,000 licensed dispensary workers and nearly 8,000 additional employees in cultivation. Dispensary tax revenue brought in $438 million for fiscal year 2025.
State officials announced last year that they would temporarily halt issuing new cannabis licenses as the market approaches its 500-license limit, allowing existing businesses time to stabilize and grow.

In Chicago, lawmakers recently pushed to prohibit most h**p-derived THC products, a move that could have strengthened licensed adult-use cannabis sales. However, Brandon Johnson vetoed the proposal last week, citing concerns about the possible negative consequences of what he described as a prohibition-style ban.

18/02/2026

Florida 2026 Cannabis Legalization Campaign’s Valid Signatures Lawsuit Sent to Supreme Court

The Florida Supreme Court is weighing whether to take up a case that could revive Smart & Safe Florida’s 2026 effort to legalize adult-use cannabis. On Feb. 16, the Florida 1st District Court of Appeal forwarded the campaign’s notice seeking discretionary review, opening the door for the high court to consider the dispute.

The case began after Cord Byrd instructed all 67 county supervisors of elections to invalidate 28,752 petition signatures gathered by non-U.S. citizens or non-Florida residents, along with another 41,894 signatures from voters labeled as “inactive.” In total, 70,646 signatures are at issue. On Jan. 23, a three-judge appellate panel sided with Byrd, ruling his directives were lawful. The panel overturned a lower court decision by Leon County Circuit Judge Jonathan E. Sjostrom that had found the invalidation of the “inactive” voter petitions unlawful, though both courts agreed the other 28,752 signatures should be thrown out.

Following the appellate ruling, Smart & Safe Florida’s general counsel, Glenn Burhans Jr., filed an emergency motion requesting a rehearing before all 12 judges of the appellate court. He argued that, with less than six weeks remaining in the petition verification process, the secretary’s actions contradicted decades of established election procedures regarding “inactive” voters—without any change in statute or court precedent to justify it. He also noted that these voters could still appear on Election Day with proper identification and cast ballots, a point the appellate court did not dispute. However, as the 30-day deadline to seek Supreme Court review approached, Burhans withdrew the rehearing request and instead petitioned the state’s highest court to intervene.

The legal fight comes after Byrd’s office announced on Feb. 1 that none of Florida’s 22 proposed constitutional amendments by citizen initiative had met the required signature threshold. According to the Florida Division of Elections, Smart & Safe Florida fell 96,460 signatures short of the 880,062 required for ballot placement. While the disputed 70,646 signatures alone would not close that gap, a recent analysis by Cannabis Business Times found that more than 54,000 validated signatures from over 30 counties were not reflected in the state’s totals.

The uncounted signatures reportedly included 16,044 from Broward County, 12,165 from Seminole County and 11,083 from Pinellas County. Officials from those counties stated their published totals were final and directed questions about discrepancies to the state. Although the Division of Elections notes that its online totals do not represent the secretary’s final determination of valid signatures, there is no statutory requirement compelling further updates beyond what is currently displayed.

Smart & Safe Florida previously prevailed in a separate lawsuit requiring Byrd and Division of Elections Director Maria Matthews to update the state’s website after nearly two months without changes. However, the judge ruled the state was only obligated to provide one final update ahead of the Feb. 1 deadline. Given the inconsistencies between county and state counts, additional legal challenges may still emerge.

06/02/2026

Sponsor & Exhibit at ICBC Berlin: April 13-15, 2026
Europe’s cannabis sector is growing at a rapid pace, bringing increased competition, fresh market players, and a limited window for brands to secure a strong leadership position.

ICBC Berlin 2026 places your company at the heart of Europe’s most powerful cannabis business network. As the continent’s largest and longest-established B2B cannabis conference, it gathers operators, policymakers, investors, and service providers who are actively shaping the future of the industry across Germany and the wider European market.

Sponsoring or exhibiting at ICBC Berlin gives you direct exposure to a focused audience of decision-makers at a time when European markets are expanding quickly.

You’ll have the opportunity to engage directly with:

Medical cannabis companies and pharmacies managing Germany’s fast-growing import and distribution landscape

Cultivation groups, social clubs, and grow shops fueling demand for genetics, equipment, and support services

Global executives and investors seeking partnerships and entry into emerging European markets

Regulators and policy specialists guiding the next stage of cannabis regulation and modernization across Europe.

05/02/2026

State of the Market 2026: Navigating the New Cannabis Landscape
The cannabis industry is entering a new phase in 2026: one defined less by speculative hype and more by operational reality. AlphaRoot’s State of the Market 2026 report delivers a data-backed look at how cannabis insurance, risk, and compliance are evolving across cultivation, manufacturing, retail, and ancillary businesses.

Designed for founders, executives, and risk managers, this guide breaks down what’s changing, what’s stabilizing, and where operators should focus next as the market matures. Inside the report, you’ll find:

A vertical-by-vertical breakdown of risk across cultivation, manufacturing, retail, and ancillary services
2026 insurance market benchmarks, including General Liability, Product Liability, D&O, EPL, Workers’ Comp, Crime, and Cyber
Federal and regulatory outlooks, including Schedule III implications and consolidation trends
And much more! Whether you’re scaling your first facility or managing a multi-state portfolio, this report provides actionable insight into how underwriters are evaluating cannabis businesses today and what operators can do to strengthen their position heading into 2026.

04/02/2026

Two Of The Cannabis Industry’s Most Acclaimed And Successful Edibles Brands Are Joining Forces, Combining Their Market Expertise, Distribution Networks And Product Innovation Pipelines To Create The Unquestioned Leader In Cannabis Edibles

PORTLAND, Ore., Jan. 5, 2026 (Globe Newswire) — Wyld, one of North America’s most recognized cannabis edibles brands, has announced plans to acquire Grön, a women-led edibles company celebrated for its premium products and creative approach. Both companies were founded and are still based in Oregon, sharing strong ties to the market that helped shape the edibles industry. The acquisition is expected to close in the first quarter of 2026, pending regulatory approval.

The merger brings together two leading names in the $4.8-billion cannabis edibles sector, united by similar values, product standards, and a long-term vision for building a trusted and comprehensive product lineup. The deal aims to strengthen quality, innovation, and sustained growth while expanding Grön’s access to markets where Wyld already operates. Grön will continue running its core business as usual, with the acquisition focused on enhancing operational support rather than changing what consumers already enjoy.
Wyld Founder and CEO Aaron Morris said the goal is to help an already successful brand grow further by combining Grön’s creativity with Wyld’s infrastructure and operational strength—without altering what makes Grön unique.

Together with Wyld and Good Tide, the combined portfolio will offer a wide range of edibles—from fruit gummies and chocolates to rosin-based products—while each brand maintains its own identity. There are no plans to change existing products, formulas, or branding, and Grön will continue operating independently with its established creative direction.

Grön Founder and CEO Christine Apple noted that the partnership allows the company to scale thoughtfully while staying true to its original mission centered on quality, creativity, and customer trust. Both companies share similar values and a commitment to producing high-quality edibles while reaching more consumers.
Following the acquisition, the combined organization expects stronger supply chains, improved ex*****on, and continued innovation. Wyld products are currently sold in 16 U.S. states and Canada across roughly 7,500 retail locations, while Grön offers 75 products across nine U.S. states and Canada in nearly 4,500 stores. The merged company will include about 1,400 employees, with Grön’s existing team continuing to lead brand strategy and product development.

The transaction was handled by legal teams from Perkins Coie representing Wyld and Feuerstein Kulick representing Grön.
Wyld, launched in 2016, is known for fruit-based cannabis edibles made with natural ingredients and developed by food scientists. The company focuses on innovation, environmental responsibility, and social impact. Its portfolio also includes Good Tide, a sustainability-focused hash rosin gummy brand inspired by coastal culture, with operations expanding across THC and CBD markets in the U.S. and Canada.

03/02/2026

SAM Contributes $1.55 Million to Massachusetts Cannabis Prohibition Campaign
Smart Approaches to Ma*****na single-handedly funded the signature drive for a 2026 ballot proposal to end adult-use sales in the commonwealth.

A leading U.S.-based organization known for opposing cannabis legalization is bankrolling efforts to dismantle Massachusetts’ regulated adult-use ma*****na industry.

Smart Approaches to Ma*****na (SAM) Action Inc. provided $1.55 million during the final quarter of 2025 to the Coalition for a Healthy Massachusetts Inc., according to recently filed campaign finance disclosures. The filing shows that SAM Action was the coalition’s sole source of funding.

Most of that money—about $1.44 million—was used to gather 78,301 certified signatures, a total confirmed last month by the office of Secretary of the Commonwealth William Galvin. Certification of the signatures allows the initiative to move forward toward potential placement on the 2026 ballot. If approved by voters, the proposal would shut down Massachusetts’ $1.6 billion adult-use cannabis industry, including retail, cultivation, and manufacturing operations.

The measure, titled “An Act to Restore a Sensible Ma*****na Policy,” would also reinstate criminal penalties for home cultivation. Under current law, adults 21 and older may grow up to six cannabis plants, with a household cap of 12 plants. While the proposal would eliminate this allowance, possession of up to one ounce of cannabis or five grams of concentrate would remain decriminalized for adults.

The initiative reflects SAM’s broader approach, which seeks to curb ma*****na use while supporting decriminalization for small amounts. Although SAM operates as a 501(c)(3) nonprofit focused on education and research, its advocacy work is carried out through SAM Action, a 501(c)(4) organization that can engage in lobbying and political campaigns using non-tax-deductible contributions.

Donors to 501(c)(4) groups are not required to be publicly identified. SAM Action has stated that its funding largely comes from individuals who say they or their families have been harmed by drug use.

SAM President and CEO Kevin Sabet, who helped establish the organization’s nonprofit arm, previously served in the White House Office of National Drug Control Policy under three administrations: George W. Bush, Barack Obama, and Bill Clinton.

Following President Donald Trump’s recent executive order instructing Attorney General Pamela Bondi to accelerate the reclassification of cannabis from Schedule I to Schedule III, Sabet publicly criticized the move, expressing concern over reduced federal restrictions.

In a video response, Sabet also highlighted SAM Action’s involvement in efforts to overturn voter-approved cannabis laws at the state level.

“For the first time, I can announce our multimillion-dollar support for grassroots campaigns aimed at ending ma*****na sales and commercialization in Maine and Massachusetts,” Sabet said, adding that the organization views these efforts as a way to reclaim public health protections.

Maine officials approved a comparable ballot initiative last month, allowing organizers to begin collecting signatures for either the 2026 or 2027 election cycle. Maine’s adult-use cannabis market currently generates roughly $250 million annually.

In both Massachusetts and Maine, critics have accused petition circulators of misleading voters about the purpose of the initiatives. In Massachusetts, the State Ballot Law Commission recently held a hearing to review claims that deceptive tactics were used. Attorneys for the prohibition campaign argued that there is insufficient evidence to invalidate the 3,727 signatures necessary to derail the initiative at this stage.

Now that the proposal has been formally submitted to the Massachusetts Legislature, lawmakers have until May 5 to adopt it through legislative action. If they decline to do so, organizers must collect an additional 12,429 signatures by July 1 to qualify for the November 2026 ballot.

In Maine, Secretary of State Shenna Bellows stated last week that petition circulators are protected by the First Amendment—even if they provide misleading information to voters.

“You have a right to lie under the First Amendment,” Bellows said, explaining that her office lacks enforcement authority over the accuracy of statements made during signature collection.

On January 14, Bellows’ office issued a public warning reminding voters that signatures cannot be withdrawn once submitted and urging people to read initiative summaries and full legislative text before signing any petition.

While SAM Action has confirmed its financial backing of the Massachusetts and Maine campaigns, Maine campaign finance records reflecting that support have not yet been released.

Meanwhile, similar efforts are underway in Arizona, where opponents of legalization have introduced the “Sensible Ma*****na Policy Act for Arizona.” That campaign must gather nearly 256,000 valid signatures to put the repeal of Arizona’s $1 billion adult-use cannabis market before voters.

All three initiatives seek to overturn laws that were originally approved by voters. Massachusetts legalized adult-use cannabis in 2016 with 53.7% support, Maine passed legalization the same year with 50.3%, and Arizona approved legalization in 2020 with a 60% supermajority.

Belize Cannabis Tours

05/03/2026

02/03/2026

27/02/2026

25/02/2026

19/02/2026

18/02/2026

06/02/2026

05/02/2026

04/02/2026

03/02/2026

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share

Listing takedown request